European Study on Lymphatic Imaging and Treatments for Heart-Related and Primary Lymphatic Disorders

What this Trial Is About

Researchers are conducting a European multicenter observational study to understand the real-world use, timing, and outcomes of lymphatic interventions in patients with congenital heart disease and primary lymphatic disorders. The study focuses on assessing how early diagnosis and targeted lymphatic treatments may improve clinical symptoms, biomarkers, and complications related to fluid imbalance. Data collected both retrospectively and prospectively from participating centers aims to identify outcome predictors, evaluate disease severity, and support standardized care across Europe. The study includes patients who have undergone or are undergoing lymphatic imaging diagnostics and interventions, as well as those managed conservatively without intervention. Lymphatic interventions, like lymphatic embolization, are part of the clinical treatments being observed. Patients are included based on past medical records and ongoing routine care at specialized centers. Participants will be monitored from the time of treatment and followed yearly for up to five years to evaluate changes in symptoms, objective biomarkers, and overall clinical improvement. The study collects extensive clinical data from diagnostic procedures, interventions, and routine care to support outcome assessment. This long-term observation will help researchers understand the benefits and timing of lymphatic interventions and improve future diagnostic and therapeutic pathways.

European Registry Study on Lymphatic Interventions